RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis

Currently there is critical need for the identification of reliable biomarkers to help guide clinical management of multiple sclerosis (MS) patients. We investigated the combined roles of Response Gene to Complement 32 (RGC-32), FasL, CDC2, AKT, and IL-21 as possible biomarkers of relapse and respon...

Full description

Saved in:
Bibliographic Details
Published in:Exp Mol Pathol
Main Authors: Kruszewski, Adam M., Rao, Gautam, Tatomir, Alexandru, Hewes, Daniel, Tegla, Cosmin A., Cudrici, Cornelia D., Nguyen, Vingh, Royal, Walter, Bever, Christopher T., Rus, Violeta, Rus, Horea
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6594183/
https://ncbi.nlm.nih.gov/pubmed/26407760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yexmp.2015.09.007
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items